Trends in Structure and Growth of Higher Fullerenes Isomer Structure of C86 and C88--Reference-Cited by-同舟云学术

Trends in Structure and Growth of Higher Fullerenes Isomer Structure of C86 and C88-

Published:2000-03 Issue:1 Volume:340 Page:553-558
ISSN:1058-725X
Container-title:Molecular Crystals and Liquid Crystals Science and Technology. Section A. Molecular Crystals and Liquid Crystals
language:en
Short-container-title:Molecular Crystals and Liquid Crystals Science and Technology. Section A. Molecular Crystals and Liquid Crystals

Author:

Miyake Yoko¹,Minami Tsuyoshi¹,Kikuchi Kouichi¹,Kainosho Masatsune¹,Achiba Yohji¹

Affiliation:

1. a Department of Chemistry , Tokyo Metropolitan University , Hachioji, 1920397, Tokyo , Japan

Publisher

Informa UK Limited

Subject

Condensed Matter Physics

Link

https://www.tandfonline.com/doi/pdf/10.1080/10587250008025524

Reference10 articles.

1. Solid C60: a new form of carbon

2. Fullerene Isomerism: Isolation of C 2 v ,-C 78 and D 3 -C 78

3. Isolation of C76, a chiral (D2) allotrope of carbon

4. NMR characterization of isomers of C78, C82 and C84 fullerenes

5. Achiba , Y. Kikuchi , K. Aihara , Y. Wakabayashi , T. Miyake , Y. and Kainosho , M. 1995. Science and Technology of Fullerene Materials, Edited by: Bernier , P. Bethune , D. S. Chiang , L. Y. and Ebbesen , T. W. 3Pittsburgh: Material Research Society.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electron–vibrational renormalization in fullerenes through ab initio and machine learning methods;Physical Chemistry Chemical Physics;2024

2. Chlorination-Promoted Skeletal Transformations in Isolated-Pentagon Rule (IPR) Isomers of Fullerene C₈₆ to Non-IPR Chloro- and Trifluoromethyl Derivatives;Inorganic Chemistry;2023-12-16

3. Computational Insights of Dimensional Organic Materials;Covalent Materials and Hybrids: From 0D to 3D;2023-08-16

4. Chlorofullerenes with isomeric C86 carbon cages: C86(16)Cl16 and C86(17)Cl18,20;Mendeleev Communications;2023-07

5. Optical properties of nanostructured antiviral and anticancer drugs;RSC Advances;2023